MENU
STIM
AS OF
Feb 4, 01:30 PM (EDT)
Price
$1.50
Change
-$0.32 (-17.58%)
Capitalization
124.64M
34 days until earnings call
Intraday BUY SELL Signals
+Compare
STIM
Stock ticker: NASDAQ
AS OF
Feb 4, 01:30 PM (EDT)
Price
$1.50
Change
-$0.32 (-17.58%)
Capitalization
124.64M

STIM Neuronetics Forecast, Technical & Fundamental Analysis

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders... Show more

STIM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for STIM with price predictions
Feb 03, 2026

STIM in upward trend: 10-day moving average moved above 50-day moving average on January 13, 2026

The 10-day moving average for STIM crossed bullishly above the 50-day moving average on January 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

STIM moved above its 50-day moving average on January 07, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STIM advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 230 cases where STIM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for STIM moved out of overbought territory on January 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where STIM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on February 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STIM as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for STIM turned negative on February 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STIM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

STIM broke above its upper Bollinger Band on January 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.556) is normal, around the industry mean (11.546). P/E Ratio (0.000) is within average values for comparable stocks, (38.420). STIM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.636). STIM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.813) is also within normal values, averaging (38.937).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. STIM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STIM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
STIM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

STIM is expected to report earnings to fall 29.08% to -9 cents per share on March 10

Neuronetics STIM Stock Earnings Reports
Q4'25
Est.
$-0.09
Q3'25
Est.
$-0.13
Q2'25
Missed
by $0.07
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.09
The last earnings report on November 04 showed earnings per share of -12 cents, meeting the estimate of -12 cents. With 888.85K shares outstanding, the current market capitalization sits at 124.64M.
A.I. Advisor
published General Information

General Information

a developer of non-invasive therapies for psychiatric and neurological disorders

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3222 Phoenixville Pike
Phone
+1 610 640-4202
Employees
203
Web
https://www.neurostar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCVNF0.900.01
+0.63%
Tocvan Ventures Corp.
HBRIY3.250.01
+0.23%
Harbour Energy Plc
INOQ9.00N/A
N/A
TPT Strategic Inc
EGHSF12.93-0.61
-4.51%
Enghouse Systems Ltd.
TELNY16.37-0.78
-4.55%
Telenor ASA

STIM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STIM has been loosely correlated with TMCI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if STIM jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
-4.78%
TMCI - STIM
35%
Loosely correlated
-2.59%
BWAY - STIM
34%
Loosely correlated
-0.56%
SYK - STIM
33%
Loosely correlated
-0.38%
PRCT - STIM
33%
Poorly correlated
+0.62%
VREX - STIM
32%
Poorly correlated
+1.58%
More

Groups containing STIM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
-4.78%
Health Services
category (410 stocks)
1%
Poorly correlated
-0.91%
Medical/Nursing Services
category (216 stocks)
1%
Poorly correlated
-0.81%